Developing novel therapies that transform lives is a partnership with you.

Let’s start the journey together.

Quick Search

FEATURED TRIALS

Epilepsy study thumbnail
Focal Epilepsy

A Study to Evaluate the Efficacy, Safety, and Tolerability of BHV-7000 in Patients with Focal Epilepsy (Rise)

Drug: BHV-7000
Age: 18-75
Phase: 3

A woman with her hand in her head
Obsessive Compulsive Disorder (OCD)

Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder

Drug: Troriluzole
Age: 18-65
Phase: 3

A senior man with glasses smiling
Multiple Myeloma (MM)

Antibody Recruiting Molecule BHV-1100 with Autologous Memory-like Natural Killer Cell Therapy Plus Intravenous Immunoglobulin, Followed by Low-Dose IL-2 in Multiple Myeloma Patients in the Peri-autologous Stem Cell Transplant Setting

Drug: BHV-1100
Age: 18-75
Phase: 1

OUR FAMILY IS WORKING HARD FOR YOU

Biohaven is a clinical-stage pharmaceutical company.

Throughout his career as a practicing physician, Associate Clinical Professor of Psychiatry and as Biohaven’s Chairman and CEO, Dr. Vlad Coric is dedicated to advancing treatment for brain disorders and other rare and common diseases.

Watch Dr. Coric's Story

Clinical trials can transform lives.

Finding new treatments that improve people’s health and change lives involves rigorous study in clinical trials before they are approved for use. Being part of a clinical trial has the potential to not only improve the lives of participants, but the lives of others as well.

Learn More

WE ARE SOCIAL

Circle Burst Artwork

Biohaven is dedicated to improving the lives of patients and caregivers through the promise of clinical research.

Find a Trial